MARVELD1 and lung cancer: Therefore, we deducted that MARVELD1 silencing may be required for tumorigenesis and has a potential to be developed as a biomarker for malignant phenotype of lung cancer, which possesses considerable value in prognosis prediction, progression monitoring and treatment evaluating.